$BCRX
BIOCRYST PHARMACEUTICALS INC

2020 Q4 Form 10-Q Financial Statement

#000117184320007740 Filed on November 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $4.016M $6.102M $1.775M
YoY Change -89.89% 243.77% 22.08%
Cost Of Revenue $80.00K $1.517M $0.00
YoY Change -96.89%
Gross Profit $3.940M $4.585M $1.775M
YoY Change -89.39% 158.31% 22.08%
Gross Profit Margin 98.11% 75.14% 100.0%
Selling, General & Admin $20.99M $17.20M $11.74M
YoY Change 100.1% 46.53% 48.11%
% of Gross Profit 532.74% 375.03% 661.13%
Research & Development $35.35M $30.25M $25.12M
YoY Change 32.05% 20.4% 14.15%
% of Gross Profit 897.21% 659.65% 1415.21%
Depreciation & Amortization $180.0K $170.0K $180.0K
YoY Change 0.0% -5.56% -5.26%
% of Gross Profit 4.57% 3.71% 10.14%
Operating Expenses $56.34M $47.44M $36.86M
YoY Change 51.21% 28.72% 23.14%
Operating Profit -$52.40M -$42.86M -$35.10M
YoY Change 47536.36% 22.13% 23.18%
Interest Expense -$6.080M $2.927M $3.044M
YoY Change 142.23% -3.84% 29.75%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$60.49M -$46.12M -$37.59M
YoY Change 2208.78% 22.69% 26.99%
Income Tax
% Of Pretax Income
Net Earnings -$60.49M -$46.12M -$37.59M
YoY Change 2207.13% 22.67% 27.01%
Net Earnings / Revenue -1506.3% -755.74% -2117.86%
Basic Earnings Per Share
Diluted Earnings Per Share -$342.4K -$261.3K -$340.4K
COMMON SHARES
Basic Shares Outstanding 176.6M 176.6M
Diluted Shares Outstanding 176.5K 110.4M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $300.4M $143.3M $68.44M
YoY Change 120.49% 109.42% -43.12%
Cash & Equivalents $272.1M $96.49M $29.90M
Short-Term Investments $28.24M $46.83M $38.53M
Other Short-Term Assets $7.700M $7.400M $4.900M
YoY Change 28.33% 51.02% 25.64%
Inventory $7.039M $6.241M $1.776M
Prepaid Expenses
Receivables $8.646M $5.422M $3.598M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $323.8M $162.4M $78.80M
YoY Change 97.02% 106.13% -38.67%
LONG-TERM ASSETS
Property, Plant & Equipment $7.113M $7.142M $7.452M
YoY Change -3.18% -4.16% -19.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.000M $0.00
YoY Change -100.0%
Other Assets $3.802M $3.646M $4.245M
YoY Change 5.91% -14.11% 198.94%
Total Long-Term Assets $10.92M $13.79M $11.70M
YoY Change -0.2% 17.89% -70.62%
TOTAL ASSETS
Total Short-Term Assets $323.8M $162.4M $78.80M
Total Long-Term Assets $10.92M $13.79M $11.70M
Total Assets $334.7M $176.2M $90.50M
YoY Change 90.96% 94.72% -46.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.71M $11.62M $10.08M
YoY Change 33.78% 15.19% 27.47%
Accrued Expenses $33.94M $30.46M $24.95M
YoY Change 58.87% 22.07% 65.04%
Deferred Revenue
YoY Change
Short-Term Debt $30.00M $29.90M $29.50M
YoY Change 1.35% 1.36% 1.72%
Long-Term Debt Due $0.00 $19.10M $4.000M
YoY Change -100.0% 377.5% 135.29%
Total Short-Term Liabilities $105.7M $111.8M $82.17M
YoY Change 14.42% 36.03% 27.68%
LONG-TERM LIABILITIES
Long-Term Debt $119.7M $26.90M $46.00M
YoY Change -41.52% 48.39%
Other Long-Term Liabilities $3.900M $3.900M $3.543M
YoY Change 14.71% 10.08% 3443.0%
Total Long-Term Liabilities $119.7M $30.80M $3.543M
YoY Change 769.32% -88.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $105.7M $111.8M $82.17M
Total Long-Term Liabilities $119.7M $30.80M $3.543M
Total Liabilities $225.4M $142.6M $85.71M
YoY Change 144.1% 66.37% -10.16%
SHAREHOLDERS EQUITY
Retained Earnings -$1.023B -$962.9M -$838.0M
YoY Change 21.75% 14.91% 18.94%
Common Stock $1.769M $1.766M $1.104M
YoY Change 14.8% 59.96% 0.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$19.26M $33.64M -$41.25M
YoY Change
Total Liabilities & Shareholders Equity $334.7M $176.2M $90.50M
YoY Change 90.96% 94.72% -46.23%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$60.49M -$46.12M -$37.59M
YoY Change 2207.13% 22.67% 27.01%
Depreciation, Depletion And Amortization $180.0K $170.0K $180.0K
YoY Change 0.0% -5.56% -5.26%
Cash From Operating Activities -$44.64M -$38.26M -$27.64M
YoY Change 327.59% 38.42% -21.1%
INVESTING ACTIVITIES
Capital Expenditures -$150.0K -$170.0K -$80.00K
YoY Change 87.5% 112.5% 100.0%
Acquisitions
YoY Change
Other Investing Activities $21.57M -$33.89M $23.60M
YoY Change 32.01% -243.6% -348.95%
Cash From Investing Activities $21.41M -$34.06M $23.51M
YoY Change 31.67% -244.87% -346.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 198.9M -4.630M 190.0K
YoY Change 153.47% -2536.84% -99.7%
NET CHANGE
Cash From Operating Activities -44.64M -38.26M -27.64M
Cash From Investing Activities 21.41M -34.06M 23.51M
Cash From Financing Activities 198.9M -4.630M 190.0K
Net Change In Cash 175.6M -76.95M -3.940M
YoY Change 108.4% 1853.05% -120.34%
FREE CASH FLOW
Cash From Operating Activities -$44.64M -$38.26M -$27.64M
Capital Expenditures -$150.0K -$170.0K -$80.00K
Free Cash Flow -$44.49M -$38.09M -$27.56M
YoY Change 329.44% 38.21% -21.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
176565622
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
176566000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
176566000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154082000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154082000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
0 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96492000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114172000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2213000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1551000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
46827000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
22054000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5422000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22146000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
6241000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5241000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4422000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
162436000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
164345000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
3002000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7142000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7347000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3646000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3590000 USD
CY2020Q3 us-gaap Assets
Assets
176226000 USD
CY2019Q4 us-gaap Assets
Assets
175282000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11616000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13988000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30462000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21365000 USD
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
19304000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
14904000 USD
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
432000 USD
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2120000 USD
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
925000 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1377000 USD
CY2020Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
19148000 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
9020000 USD
CY2020Q3 us-gaap Notes Payable Current
NotesPayableCurrent
29890000 USD
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
29561000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
111777000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
92335000 USD
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3919000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3406000 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
26893000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
41289000 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
877300000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9000 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
1766000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1541000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
994811000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
39000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-962949000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-840628000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
33637000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
38252000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176226000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
175282000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6102000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1775000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13796000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9110000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1517000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1517000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1399000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30245000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25120000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
87610000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
80294000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17195000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11735000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46943000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26632000 USD
CY2020Q3 us-gaap Royalty Expense
RoyaltyExpense
9000 USD
CY2019Q3 us-gaap Royalty Expense
RoyaltyExpense
18000 USD
us-gaap Royalty Expense
RoyaltyExpense
78000 USD
us-gaap Royalty Expense
RoyaltyExpense
131000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
48966000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
36873000 USD
us-gaap Costs And Expenses
CostsAndExpenses
136148000 USD
us-gaap Costs And Expenses
CostsAndExpenses
108456000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-42864000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35098000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-122352000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-99346000 USD
CY2020Q3 bcrx Interest And Other Income Loss
InterestAndOtherIncomeLoss
-312000 USD
CY2019Q3 bcrx Interest And Other Income Loss
InterestAndOtherIncomeLoss
402000 USD
bcrx Interest And Other Income Loss
InterestAndOtherIncomeLoss
8892000 USD
bcrx Interest And Other Income Loss
InterestAndOtherIncomeLoss
1545000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
2927000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
3044000 USD
us-gaap Interest Expense
InterestExpense
8892000 USD
us-gaap Interest Expense
InterestExpense
8805000 USD
CY2020Q3 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-12000 USD
CY2019Q3 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
148000 USD
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
31000 USD
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
331000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-46115000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-37592000 USD
us-gaap Net Income Loss
NetIncomeLoss
-122321000 USD
us-gaap Net Income Loss
NetIncomeLoss
-106275000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
19000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-30000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
14031000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1061000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
936000 USD
bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
106000 USD
bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
1000 USD
us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-630000 USD
us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-532000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-16724000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-695000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
357000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46109000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37573000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-122351000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-105918000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.96
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176521000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110416000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164127000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110308000
us-gaap Net Income Loss
NetIncomeLoss
-122321000 USD
us-gaap Net Income Loss
NetIncomeLoss
-106275000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
568000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
539000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8907000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6241000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
127000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1448000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1018000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6725000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9975000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4400000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1575000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1688000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92577000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79136000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
359000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
263000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
49818000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3018000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
21907000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
64954000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28270000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
61673000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
92848000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
14817000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1164000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1161000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-38607000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
532000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
92848000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
14817000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3280000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
76507000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-46115000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
366000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2873000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
19477000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
-0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
103829000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20638000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17018000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3175000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115723000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28275000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98705000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31450000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
38252000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-37599000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-25000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
266000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2754000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
3648000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
33637000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
49235000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-31054000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
208000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
343000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
220000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3317000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
22507000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-37629000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
130000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
414000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5385000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-9193000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-37592000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
19000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
184000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5329000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-41253000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
49789000 USD
CY2020Q3 bcrx Available For Sale Debt Securities Accrued Interest
AvailableForSaleDebtSecuritiesAccruedInterest
31000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
9000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
-0 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
49829000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
21899000 USD
CY2019Q4 bcrx Available For Sale Debt Securities Accrued Interest
AvailableForSaleDebtSecuritiesAccruedInterest
116000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
40000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
22054000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
46827000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
22054000 USD
CY2020Q3 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
3002000 USD
CY2019Q4 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
0 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
49829000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
22054000 USD
CY2020Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
5422000 USD
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
22146000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13796000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9110000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
206000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6035000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
1000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6102000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1775000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2927000 USD
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3044000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
8892000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
8805000 USD
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
381000 USD
CY2019Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
341000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1061000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
936000 USD
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16544000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
541000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14154000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1892000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><b>Use of Estimates</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:28.7pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The most significant estimates in the Company’s consolidated financial statements relate to the valuation of stock options, and the valuation allowance for deferred tax assets resulting from net operating losses. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are <em style="font: inherit;">not</em> readily apparent from other sources. Actual results could differ from those estimates.</p>
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8907000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14031000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
21884000 USD
CY2020Q3 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized For Remainder Of Fiscal Year
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedForRemainderOfFiscalYear
2708000 USD
CY2020Q3 bcrx Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Next Year
EmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedNextYear
8461000 USD
CY2020Q3 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Two
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearTwo
6983000 USD
CY2020Q3 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Three
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearThree
3137000 USD
CY2020Q3 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Four
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearFour
595000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
5000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
20000000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
20000000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
45000000 USD
CY2020Q2 bcrx Maximum Aggregate Offering Price
MaximumAggregateOfferingPrice
500000000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
22044447
CY2020Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.50
CY2020Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
107665000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y8M12D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.128 pure
us-gaap Operating Lease Expense
OperatingLeaseExpense
1321000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1064000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
403000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
851000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
746000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
608000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
577000 USD
CY2020Q3 bcrx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
7908000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11093000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6249000 USD

Files In Submission

Name View Source Status
0001171843-20-007740-index-headers.html Edgar Link pending
0001171843-20-007740-index.html Edgar Link pending
0001171843-20-007740.txt Edgar Link pending
0001171843-20-007740-xbrl.zip Edgar Link pending
bcrx-20200930.xsd Edgar Link pending
bcrx-20200930_cal.xml Edgar Link unprocessable
bcrx-20200930_def.xml Edgar Link unprocessable
bcrx-20200930_lab.xml Edgar Link unprocessable
bcrx-20200930_pre.xml Edgar Link unprocessable
bcrx20200930_10q.htm Edgar Link pending
bcrx20200930_10q_htm.xml Edgar Link completed
exh102_1.jpg Edgar Link pending
exh102_2.jpg Edgar Link pending
exh102_3.jpg Edgar Link pending
exh102_4.jpg Edgar Link pending
exh102_5.jpg Edgar Link pending
exh102_6.jpg Edgar Link pending
exh103.jpg Edgar Link pending
exh104_01.jpg Edgar Link pending
exh104_02.jpg Edgar Link pending
exh104_03.jpg Edgar Link pending
exh104_04.jpg Edgar Link pending
exh104_05.jpg Edgar Link pending
exh104_06.jpg Edgar Link pending
exh104_07.jpg Edgar Link pending
exh104_08.jpg Edgar Link pending
exh104_09.jpg Edgar Link pending
exh104_10.jpg Edgar Link pending
exh104_11.jpg Edgar Link pending
exh104_12.jpg Edgar Link pending
exh104_13.jpg Edgar Link pending
exh104_14.jpg Edgar Link pending
exh104_15.jpg Edgar Link pending
exh104_16.jpg Edgar Link pending
exh104_17.jpg Edgar Link pending
exh104_18.jpg Edgar Link pending
exh104_19.jpg Edgar Link pending
exh104_20.jpg Edgar Link pending
exh104_21.jpg Edgar Link pending
exh104_22.jpg Edgar Link pending
exh104_23.jpg Edgar Link pending
exh104_24.jpg Edgar Link pending
exh104_25.jpg Edgar Link pending
exh104_26.jpg Edgar Link pending
exh104_27.jpg Edgar Link pending
exh104_28.jpg Edgar Link pending
exh104_29.jpg Edgar Link pending
exh104_30.jpg Edgar Link pending
exh104_31.jpg Edgar Link pending
exh104_32.jpg Edgar Link pending
exh104_33.jpg Edgar Link pending
exh104_34.jpg Edgar Link pending
exh104_35.jpg Edgar Link pending
exh104_36.jpg Edgar Link pending
exh104_37.jpg Edgar Link pending
exh104_38.jpg Edgar Link pending
exh104_39.jpg Edgar Link pending
exh104_40.jpg Edgar Link pending
exh104_41.jpg Edgar Link pending
exh104_42.jpg Edgar Link pending
exh104_43.jpg Edgar Link pending
exh104_44.jpg Edgar Link pending
exh104_45.jpg Edgar Link pending
exh104_46.jpg Edgar Link pending
exh105_1.jpg Edgar Link pending
exh105_2.jpg Edgar Link pending
exh105_3.jpg Edgar Link pending
exh108_1.jpg Edgar Link pending
exh108_2.jpg Edgar Link pending
ex_210552.htm Edgar Link pending
ex_210553.htm Edgar Link pending
ex_210554.htm Edgar Link pending
ex_210555.htm Edgar Link pending
ex_211509.htm Edgar Link pending
ex_211510.htm Edgar Link pending
ex_211511.htm Edgar Link pending
ex_211512.htm Edgar Link pending
ex_211514.htm Edgar Link pending
ex_211515.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending